10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Standardized uptake value ratios (SUVRs) calculated from cerebral cortical areas can be used to categorize 18F-Florbetaben (FBB) PET scans by applying appropriate cutoffs. The objective of this work was first to generate FBB SUVR cutoffs using visual assessment (VA) as standard of truth (SoT) for a number of reference regions (RR) (cerebellar gray matter (GCER), whole cerebellum (WCER), pons (PONS), and subcortical white matter (SWM)). Secondly, to validate the FBB PET scan categorization performed by SUVR cutoffs against the categorization made by post-mortem histopathological confirmation of the Aβ presence. Finally, to evaluate the added value of SUVR cutoff categorization to VA.

          Methods

          SUVR cutoffs were generated for each RR using FBB scans from 143 subjects who were visually assessed by 3 readers. SUVR cutoffs were validated in 78 end-of life subjects using VA from 8 independent blinded readers (3 expert readers and 5 non-expert readers) and histopathological confirmation of the presence of neuritic beta-amyloid plaques as SoT. Finally, the number of correctly or incorrectly classified scans according to pathology results using VA and SUVR cutoffs was compared.

          Results

          Composite SUVR cutoffs generated were 1.43 (GCER), 0.96 (WCER), 0.78 (PONS) and 0.71 (SWM). Accuracy values were high and consistent across RR (range 83–94% for histopathology, and 85–94% for VA). SUVR cutoff performed similarly as VA but did not improve VA classification of FBB scans read either by expert readers or the majority read but provided higher accuracy than some non-expert readers.

          Conclusion

          The accurate scan classification obtained in this study supports the use of VA as SoT to generate site-specific SUVR cutoffs. For an elderly end of life population, VA and SUVR cutoff categorization perform similarly in classifying FBB scans as Aβ-positive or Aβ-negative. These results emphasize the additional contribution that SUVR cutoff classification may have compared with VA performed by non-expert readers.

          Highlights

          • SUVR cutoffs to classify Florbetaben PET scans as positive and negative were generated.

          • SUVR cutoffs were validated against post-mortem histopathological confirmation.

          • Added value of SUVR cutoff classification to visual assessment was evaluated.

          • SUVR cutoff classification provided higher accuracy than some non-expert readers.

          • Results emphasize the contribution that SUVR cutoffs may have to visual assessment.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: not found
          • Article: not found

          THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

            Bookmark
            • Record: found
            • Abstract: not found
            • Book: not found

            Conspectus florae Graecae / auctore E. de Halácsy.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.

              Amyloid imaging with (18)F-labeled radiotracers will allow widespread use, facilitating research, diagnosis, and therapeutic development for Alzheimer disease. The purpose of the study program was to compare cortical amyloid deposition using (18)F-florbetaben and PET in controls and subjects with mild cognitive impairment (MCI), frontotemporal lobar degeneration (FTLD), dementia with Lewy bodies (DLB), vascular dementia (VaD), Parkinson disease (PD), and Alzheimer disease (AD). One hundred nine subjects in 3 clinical studies at Austin Health were reviewed: 32 controls, 20 subjects with MCI, and 30 patients with AD, 11 with FTLD, 7 with DLB, 5 with PD, and 4 with VaD underwent PET after intravenous injection of 300 MBq of (18)F-florbetaben. Standardized uptake value ratios (SUVR) using the cerebellar cortex as a reference region were calculated between 90 and 110 min after injection. When compared with the other groups, AD patients demonstrated significantly higher SUVRs (P < 0.0001) in neocortical areas. Most AD patients (96%) and 60% of MCI subjects showed diffuse cortical (18)F-florbetaben retention. In contrast, only 9% of FTLD, 25% of VaD, 29% of DLB, and no PD patients and 16% of controls showed cortical binding. Although there was a correlation between Mini Mental State Examination and β-amyloid burden in the MCI group, no correlation was observed in controls, FTLD or AD. (18)F-florbetaben had high sensitivity for AD, clearly distinguished patients with FTLD from AD, and provided results comparable to those reported with (11)C-Pittsburgh Compound B in a variety of neurodegenerative diseases.
                Bookmark

                Author and article information

                Contributors
                Journal
                Neuroimage Clin
                Neuroimage Clin
                NeuroImage : Clinical
                Elsevier
                2213-1582
                13 May 2017
                2017
                13 May 2017
                : 15
                : 325-332
                Affiliations
                [a ]Piramal Imaging GmbH, Berlin, Germany
                [b ]Molecular Neuroimaging, New Haven, CT, USA
                [c ]Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany
                [d ]Piramal Pharma Inc., Boston, MA, USA
                Author notes
                [* ]Corresponding author at: Tegeler Straße 6-7, 13353 Berlin, Germany.Tegeler Straße 6-7Berlin13353Germany santi.bullich@ 123456piramal.com
                Article
                S2213-1582(17)30102-X
                10.1016/j.nicl.2017.04.025
                5440277
                28560157
                05949611-08ef-4452-91b9-267c4df9db36
                © 2017 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 20 February 2017
                : 24 April 2017
                : 25 April 2017
                Categories
                Regular Article

                florbetaben,pet,suvr,quantification,visual assessment
                florbetaben, pet, suvr, quantification, visual assessment

                Comments

                Comment on this article